Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Yuling Xiao(Shenzhen University), Jinjun Shi(Brigham and Women's Hospital)
Nature Communications
February 9, 2022
Cited by 255


Related Papers